Citations

Showing 10 of 108094 citations.

The diagnosis of progressive supranuclear palsy: current opinions and challenges
Ali, Farwa , Josephs, Keith A. , Josephs, Keith

Mayo Clinic

Expert Review of Neurotherapeutics | June 14, 2018 | Volume: 18 | Issue: 7 | Pages: 603-616

10.1080/14737175.2018.1489241 | PMID 29902389 Get It

Adductor Canal Versus Femoral Triangle: Let Us All Get on the Same Page
Panchamia, Jason K. , Niesen, Adam D. , Amundson, Adam W.

Mayo Clinic

Anesthesia & Analgesia | June 14, 2018 | Volume: 127 | Issue: 3 | Pages: e50-e50

10.1213/ane.0000000000003570 | PMID 29905612 Get It

Two-dimensional exchange spectroscopy revisited: Accounting for the number of participating spins
Juranić, Nenad, Zolnai, Z. , Macura, Slobodan , Macura, Slobodan I

Mayo Clinic

Journal of the Serbian Chemical Society | June 14, 2018 | Volume: 65 | Issue: 5-6 | Pages: 285-301

10.2298/jsc0006285j Get It

The magnetization exchange between two groups of equivalent spins each having different populations and overall relaxation rates has been analyzed. The results suggest that either the spin population difference or the overall relaxation rate difference in an exchange spectrum can produce cross-peaks with volumes larger than that of the corresponding diagonal line. This is important for interpretation of the magnetization exchange between water and macromolecular protons where both the population differences and auto-relaxation rate differences can be very large. Theoretical predictions of peak volume evolution were experimentally verified in the intermolecular magnetization exchange between the water and labile amide proton in a model system N-acetylglycine/water.
Proteomic analysis reveals co-ordinated alterations in protein synthesis and degradation pathways in LRRK2 knockout mice
Pellegrini, Laura , Hauser, David N. , Li, Yan , Mamais, Adamantios , Beilina, Alexandra , Kumaran, Ravindran, Wetzel, Andrea, Nixon‐Abell, Jonathon , Heaton, George R., Rudenko, Iakov N., Alkaslasi, Mor R. , Ivanina, Natalie, Melrose, Heather L. , Cookson, Mark , Harvey, Kirsten

Mayo Clinic

Human Molecular Genetics | June 14, 2018 | Volume: 27 | Issue: 18 | Pages: 3257-3271

10.1093/hmg/ddy232 | PMID 29917075 Get It

Upfront low‐dose ponatinib (15 mg/day) for multi‐TKI resistant chronic myeloid leukemia
Tefferi, Ayalew

Mayo Clinic

Hematological Oncology | June 14, 2018 | Volume: 36 | Issue: 4 | Pages: 718-720

10.1002/hon.2517 | PMID 29901221 Get It

Joint contracture is reduced by intra‐articular implantation of rosiglitazone‐loaded hydrogels in a rabbit model of arthrofibrosis
Arsoy, Diren , Salib, Christopher G. , Trousdale, William H. , Tibbo, Meagan E. , Limberg, Afton K. , Lewallen, Eric A. , Reina, Nicolas , Yaszemski, Michael J. , Berry, Daniel J., Wijnen, André J. van , Berry, Daniel J. , Viste, Anthony , Reina, Nicolas , Sanchez-Sotelo, Joaquin, van Wijnen, Andre J , Berry, Daniel J , Berry, Daniel J., Morrey, Mark E. , Sánchez‐Sotelo, Joaquín , Abdel, Matthew P.

Mayo Clinic

Journal of Orthopaedic Research | June 14, 2018 | Volume: 36 | Issue: 11 | Pages: 2949-2955

10.1002/jor.24068 | PMID 29901247 Get It

ABSTRACTTrauma, surgery, and other inflammatory conditions can lead to debilitating joint contractures. Adjunct pharmacologic modalities may permit clinical prevention and treatment of recalcitrant joint contractures. We investigated the therapeutic potential of rosiglitazone by intra‐articular delivery via oligo[poly(ethylene glycol)fumarate] (OPF) hydrogels in an established rabbit model of arthrofibrosis. OPF hydrogels loaded with rosiglitazone were characterized for drug elution properties upon soaking in minimum essential media (MEM) with 10% fetal bovine serum and measurements of drug concentrations via High Performance Liquid Chromatography (HPLC). Drug‐loaded scaffolds were surgically implanted into 24 skeletally mature female New Zealand White rabbits that were divided into equal groups receiving OPF hydrogels loaded with rosiglitazone (1.67 mg), or vehicle control (10 µl DMSO). After 8 weeks of joint immobilization, rabbits were allowed unrestricted cage activity for 16 weeks. Contracture angles of rabbit limbs treated with rosiglitazone showed statistically significant improvements in flexion compared to control animals (mean angles, respectively, 64.4° vs. 53.3°, p < 0.03). At time of sacrifice (week 24), animals in the rosiglitazone group continued to exhibit less joint contracture than controls (119.0° vs. 99.5°, p = 0.014). The intra‐articular delivery of rosiglitazone using implanted OPF hydrogels decreases flexion contractures in a rabbit model of arthrofibrosis without causing adverse effects (e.g., gross inflammation or arthritis). Statement of Clinical Significance: Post‐traumatic joint contractures are common and debilitating, with limited available treatment options. Pharmacologic interventions can potentially prevent and treat such contractures. This study is translational in that a commercially approved medication has been repurposed through a novel delivery device. © 2018 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:2949–2955, 2018.
YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity
Werneburg, Nathan W., Hernandez, Matthew C. , Yang, Lin , Kabashima, Ayano , Hirsova, Petra , Yohanathan, Lavanya, Sosa, Carlos, Truty, Mark J. , Vasmatzis, George , Smoot, Rory L. , Sugihara, Takaaki, Hernandez, Matthew C , Hirsova, Petra , Smoot, Rory L , Sugihara, Takaaki , Gores, Gregory J.

Mayo Clinic

Molecular Cancer Research | June 14, 2018 | Volume: 16 | Issue: 10 | Pages: 1556-1567

10.1158/1541-7786.mcr-18-0158 | PMID 29903769 Get It

Abstract The Hippo pathway effector, Yes-associated protein (YAP), is a transcriptional coactivator implicated in cholangiocarcinoma (CCA) pathogenesis. YAP is known to be regulated by a serine/threonine kinase relay module (MST1/2–LATS1/2) culminating in phosphorylation of YAP at Serine 127 and cytoplasmic sequestration. However, YAP also undergoes tyrosine phosphorylation, and the role of tyrosine phosphorylation in YAP regulation remains unclear. Herein, YAP regulation by tyrosine phosphorylation was examined in human and mouse CCA cells, as well as patient-derived xenograft (PDX) models. YAP was phosphorylated on tyrosine 357 (Y357) in CCA cell lines and PDX models. SRC family kinase (SFK) inhibition with dasatinib resulted in loss of YAPY357 phosphorylation, promoted its translocation from the nucleus to the cytoplasm, and reduced YAP target gene expression, including cell lines expressing a LATS1/2-resistant YAP mutant in which all serine residues were mutated to alanine. Consistent with these observations, precluding YAPY357 phosphorylation by site-directed mutagenesis (YAPY357F) excluded YAP from the nucleus. Targeted siRNA experiments identified LCK as the SFK that most potently mediated YAPY357 phosphorylation. Likewise, inducible CRISPR/Cas9-targeted LCK deletion decreased YAPY357 phosphorylation and its nuclear localization. The importance of LCK in CCA biology was demonstrated by clinical observations suggesting LCK expression levels were associated with early tumor recurrence following resection of CCA. Finally, dasatinib displayed therapeutic efficacy in PDX models. Mol Cancer Res; 16(10); 1556–67. ©2018 AACR.
Focusing on the Future of Cardiovascular Outcomes Research
Thompson, Michael P. , Fanaroff, Alexander C. , Parker, Joshua D., Vallabhajosyula, Saraschandra , Sterling, Madeline R. , Vallabhajosyula, Saraschandra , Fanaroff, Alexander C

Mayo Clinic

Circulation: Cardiovascular Quality and Outcomes | June 14, 2018 | Volume: 11 | Issue: 6 | Pages: No page available

10.1161/circoutcomes.118.004871 | PMID 29903937 Get It

Exploring the Role of Oncolytic Viruses in Hepatobiliary Cancers
Tenneti, Pavan , Babiker, Hani M. , Babiker, Hani , Borad, Mitesh J.

Mayo Clinic

Immunotherapy | June 14, 2018 | Volume: 10 | Issue: 11 | Pages: 971-986

10.2217/imt-2018-0048 | PMID 29900755 Get It

Plasma Ceramides
Meeusen, Jeffrey W. , Bryant, Sandra C. , Baudhuin, Linnea M. , Berger, Peter B. , Jaffe, Allan S. , Donato, Leslie J. , Jaffe, Allan S.

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | June 14, 2018 | Volume: 38 | Issue: 8 | Pages: 1933-1939

10.1161/atvbaha.118.311199 | PMID 29903731 Get It

Objective— Ceramides are sphingolipids involved with cellular signaling. Synthesis of ceramides occurs in all tissues. Ceramides accumulate within tissues and the blood plasma during metabolic dysfunction, dyslipidemia, and inflammation. Elevations of ceramides are predictive of cardiovascular mortality. We sought to verify the utility of plasma concentrations of 4 ceramides: N-palmitoyl-sphingosine [Cer(16:0)], N-stearoyl-sphingosine [Cer(18:0)], N-nervonoyl-sphingosine [Cer(24:1)], and N-lignoceroyl-sphingosine [Cer(24:0)] in predicting major adverse cardiovascular events in a diverse patient population referred for coronary angiography. Approach and Results— Plasma ceramides were measured in 495 participants before nonurgent coronary angiography. Coronary artery disease, defined as >50% stenosis in ≥1 coronary artery, was identified 265 (54%) cases. Ceramides were not significantly associated with coronary artery disease. Patients were followed for a combined primary end point of myocardial infarction, percutaneous intervention, coronary artery bypass, stroke, or death within 4 years. Ceramides were significantly predictive of outcomes after adjusting for age, sex, body mass index, hypertension, smoking, LDL (low-density lipoprotein) cholesterol, HDL (high-density lipoprotein) cholesterol, triglycerides, serum glucose, and family history of coronary artery disease. The fully adjusted per SD hazard ratios (95% confidence interval) were 1.50 (1.16–1.93) for Cer(16:0), 1.42 (1.11–1.83) for Cer(18:0), 1.43 (1.08–1.89) for Cer(24:1), and 1.58 (1.22–2.04) for the ceramide risk score. Conclusions— Elevated plasma concentrations of ceramides are independently associated with major adverse cardiovascular events in patients with and without coronary artery disease.